Bavarian Nordic (OTCMKTS:BVNRY) Shares Pass Above 50-Day Moving Average - Here's What Happened

Key Points

• Bavarian Nordic's stock price surpassed its 50-day moving average of $11.76, reaching a high of $12.07 during Thursday's trading session.
• The company reported earnings of $0.23 per share for the last quarter, with revenues totaling $251.14 million.
• Bavarian Nordic specializes in developing life-saving vaccines, including those for smallpox, monkeypox, rabies, and Ebola.

Bavarian Nordic (OTCMKTS:BVNRY - Get Free Report)'s share price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $11.76 and traded as high as $12.07. Bavarian Nordic shares last traded at $12.07, with a volume of 607 shares changing hands.

Bavarian Nordic Stock Up 0.2%

The business has a 50-day moving average price of $11.81 and a 200-day moving average price of $9.48. The firm has a market capitalization of $2.86 billion, a PE ratio of 13.82 and a beta of 1.30.

Bavarian Nordic (OTCMKTS:BVNRY - Get Free Report) last posted its quarterly earnings results on Friday, August 22nd. The company reported $0.23 earnings per share (EPS) for the quarter. The business had revenue of $251.14 million during the quarter. Bavarian Nordic had a return on equity of 12.35% and a net margin of 21.95%. On average, equities research analysts anticipate that Bavarian Nordic will post 0.67 earnings per share for the current year.

About Bavarian Nordic

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.